FR2972112B1 - Utilisation d'un compose pour le traitement des dermatoses inflammatoires - Google Patents

Utilisation d'un compose pour le traitement des dermatoses inflammatoires Download PDF

Info

Publication number
FR2972112B1
FR2972112B1 FR1151668A FR1151668A FR2972112B1 FR 2972112 B1 FR2972112 B1 FR 2972112B1 FR 1151668 A FR1151668 A FR 1151668A FR 1151668 A FR1151668 A FR 1151668A FR 2972112 B1 FR2972112 B1 FR 2972112B1
Authority
FR
France
Prior art keywords
compound
treatment
inflammatory dermatoses
denotes
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1151668A
Other languages
English (en)
Other versions
FR2972112A1 (fr
Inventor
Lacharriere Olivier De
Christian Tran
Sreekumar Pillai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1151668A priority Critical patent/FR2972112B1/fr
Publication of FR2972112A1 publication Critical patent/FR2972112A1/fr
Application granted granted Critical
Publication of FR2972112B1 publication Critical patent/FR2972112B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne un composé de formule I: R -CHOH-CH(NH-COR )(CH OH) (I) dans laquelle R désigne un radical alcoyl ou alcényl en C à C , R désigne un radical hydrocarboné en C -C linéaire et pouvant comporter une ou plusieurs insaturations éthyléniques, notamment une ou deux insaturations éthyléniques, pour son utilisation dans le traitement des signes des dermatoses inflammatoires. Elle concerne aussi un produit de combinaison, comprenant au moins un composé de formule I et au moins un corticostéroïde.
FR1151668A 2011-03-01 2011-03-01 Utilisation d'un compose pour le traitement des dermatoses inflammatoires Active FR2972112B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1151668A FR2972112B1 (fr) 2011-03-01 2011-03-01 Utilisation d'un compose pour le traitement des dermatoses inflammatoires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1151668A FR2972112B1 (fr) 2011-03-01 2011-03-01 Utilisation d'un compose pour le traitement des dermatoses inflammatoires

Publications (2)

Publication Number Publication Date
FR2972112A1 FR2972112A1 (fr) 2012-09-07
FR2972112B1 true FR2972112B1 (fr) 2020-11-06

Family

ID=44549760

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1151668A Active FR2972112B1 (fr) 2011-03-01 2011-03-01 Utilisation d'un compose pour le traitement des dermatoses inflammatoires

Country Status (1)

Country Link
FR (1) FR2972112B1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673179B1 (fr) * 1991-02-21 1993-06-11 Oreal Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
ES2207023T3 (es) * 1997-12-05 2004-05-16 Cosmoferm B.V. Composiciones que comprenden una combinacion de una base esfingoide libre y una ceramida y utilizacion de las mismas.
EP1053243B1 (fr) * 1998-02-12 2011-03-30 Emory University Derives de sphingolipides et procedes d'utilisation
FR2806301B1 (fr) * 2000-03-20 2002-10-31 Led Evolution Dermatolog Composition a base de sphingolipide et de beta-hydroxy-acide utilisable par voie topique pour les soins de la peau
JP3466995B2 (ja) * 2000-06-08 2003-11-17 花王株式会社 上がり湯用保湿剤組成物
JP2003183148A (ja) * 2001-12-20 2003-07-03 Kao Corp 皮膚外用剤組成物
FR2939041A1 (fr) * 2008-11-28 2010-06-04 Natura Cosmeticos Sa Melange hydratant, compositions cosmetiques et/ou pharmaceutiques le contenant et utilisation et methode de traitement cosmetique mettant en oeuvre ce melange

Also Published As

Publication number Publication date
FR2972112A1 (fr) 2012-09-07

Similar Documents

Publication Publication Date Title
CY1119533T1 (el) Νεοι θεραπευτικοι παραγοντες
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
EA201390843A1 (ru) Применение агониста toll-подобного рецептора для лечения рака
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
MA38143A1 (fr) Composition comprenant des agents de lutte biologique
TR201902788T4 (tr) Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri.
MX350588B (es) Composiciones de alcanos semifluorados.
MA35096B1 (fr) Cyclopropylamines en tant qu'inhibiteurs de lsd1
MY155317A (en) Benzene sulfonamide thiazole and oxazole compounds
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
WO2012040641A3 (fr) Composés de traitement de maladies neurodégénératives
CO6852097A2 (es) Agentes de coalescencia amigables con el medio ambiente
MA38645B1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
MA35086B1 (fr) Compose de triazolopyridine
MA35100B1 (fr) Analogues de l'acide époxyéicosatriénoïque et leurs procédés de fabrication et d'utilisation
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
MA39170B1 (fr) Composes inhibiteurs de sérine/thréonine kinase pour leurs utilisations dans le traitement du cancer
MA37943B1 (fr) 2-oxo-2,3-dihydro-indoles destinés au traitement de troubles du snc
BR112012032248A2 (pt) composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
MA38410A1 (fr) Composés d'azétidinyloxyphénylpyrrolidine
EA201170344A1 (ru) Азаиндольные ингибиторы iap
MA35742B1 (fr) Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques
TW200613317A (en) Steroid prodrugs with androgenic action

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14